A new study from the Netherlands Institute for Neuroscience brings together two schools of thought on the function of the neurotransmitter dopamine: one saying that dopamine provides a learning signal, the other saying that ...
Jun 6, 2023
0
4
A new study to be presented at the SLEEP 2023 annual meeting emphasizes that in addition to getting sufficient sleep each night, adults should maintain a consistent sleep schedule with a regular bedtime and wake time.
Jun 5, 2023
0
13
US pharmaceutical giant Eli Lilly on Wednesday announced its experimental Alzheimer's drug significantly slowed cognitive and functional decline, results hailed as "remarkable" by experts despite some patients experiencing ...
May 3, 2023
0
129
After spending 38 years in the Alabama prison system, one of the most violent and crowded in the nation, Larry Jordan felt lucky to live long enough to regain his freedom.
May 1, 2023
0
2
Patients with relapsed or refractory multiple myeloma who were treated with the two highest doses of REGN5459, a bispecific antibody targeting BCMA and CD3, experienced a 90.5% overall response rate, according to results ...
Apr 17, 2023
0
11
Little-known Chagas disease is a silent killer in Latin America, where it takes 10,000 lives a year, and more must be done to detect the condition early on, the Pan American Health Organization said Thursday.
Apr 13, 2023
0
2
Requirements to wear surgical masks in a large London hospital during the first 10 months of omicron activity (December 2021 to September 2022) made no discernible difference to reducing hospital-acquired SARS-CoV-2 infections, ...
Apr 7, 2023
0
425
The Perottett government's promise to introduce mandatory "cashless gambling" in New South Wales by 2028—something for which anti-gambling activists and public-health experts have long lobbied—has elicited a strong response ...
Mar 21, 2023
0
2
Using vision to efficiently move through an area by foot uses a unique region of the brain's cortex, according to a small study organized by the National Eye Institute (NEI). The region, called the occipital place area (OPA), ...
Mar 15, 2023
0
79
For patients with pretreated relapsed and refractory multiple myeloma, idecabtagene vicleucel (ide-cel), a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy, prolongs progression-free survival and ...
Feb 10, 2023
0
2
